Biotechnology Assets, S.A. (BME:BST)

Biotechnology Assets Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.42	0.2	0.35	0.69	1.68
Short-Term Investments	0.24	0.07	0.06	0.11	0.04
Cash & Short-Term Investments	0.67	0.26	0.42	0.8	1.72
Cash Growth	154.42%	-37.19%	-47.92%	-53.39%	188.31%
Accounts Receivable	3.86	3.33	3.16	2.21	2.62
Other Receivables	0.06	0.11	0.19	0.11	0.07
Receivables	3.92	3.44	3.34	2.32	2.69
Inventory	0.01	-	-	-	-
Total Current Assets	4.59	3.7	3.76	3.12	4.4
Property, Plant & Equipment	2.2	2.32	2.44	2.53	2.56
Long-Term Investments	0.25	0.45	0.57	0.37	0.36
Goodwill	0.82	1.46	2.1	2.74	3.37
Other Intangible Assets	0.75	0.92	1.14	1.36	1.59
Long-Term Deferred Tax Assets	2.43	2.67	2.76	3.33	3.33
Long-Term Deferred Charges	2.52	3.27	3.84	5.03	4.26
Total Assets	13.56	14.78	16.61	18.47	19.88

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.2	0.2	0.31	0.4	0.3
Accrued Expenses	0.7	0.87	0.75	0.64	0.8
Short-Term Debt	0.71	0.75	0.51	0.34	0.33
Current Portion of Long-Term Debt	0.32	0.46	0.26	0.25	0.21
Current Portion of Leases	0.02	0.02	0.01	-	-
Current Income Taxes Payable	0.06	0.04	0.23	0.03	0.06
Other Current Liabilities	1.26	2.22	1.53	1.88	1.85
Total Current Liabilities	3.27	4.55	3.61	3.54	3.55
Long-Term Debt	0.69	0.85	3.32	7.65	7.71
Long-Term Leases	0.01	0.01	0.03	-	-
Long-Term Deferred Tax Liabilities	0.39	0.44	0.51	0.5	0.6
Other Long-Term Liabilities	2.25	2.32	2.6	2.91	3.67
Total Liabilities	6.6	8.17	10.08	14.6	15.54

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3.64	3.3	2.89	2.72	2.29
Additional Paid-In Capital	101.61	99.76	97.12	96.35	95.14
Retained Earnings	-99.37	-97.52	-94.46	-95.97	-93.89
Treasury Stock	-0.02	-0.03	-0.05	-0.03	-0.1
Comprehensive Income & Other	1.1	1.09	1.18	0.97	1.04
Total Common Equity	6.96	6.61	6.68	4.03	4.49
Minority Interest	-0	-0	-0.15	-0.15	-0.15
Shareholders' Equity	6.96	6.61	6.53	3.87	4.34
Total Liabilities & Equity	13.56	14.78	16.61	18.47	19.88

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.74	2.09	4.14	8.25	8.25
Net Cash (Debt)	-1.08	-1.82	-3.72	-7.45	-6.53
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-	-0.03	-0.06	-0.14	-0.14
Filing Date Shares Outstanding	-	65.97	57.73	54.2	45.61
Total Common Shares Outstanding	-	65.97	57.73	54.2	45.61
Working Capital	1.32	-0.85	0.15	-0.41	0.85
Book Value Per Share	-	0.10	0.12	0.07	0.10
Tangible Book Value	5.39	4.23	3.45	-0.07	-0.47
Tangible Book Value Per Share	-	0.06	0.06	-0.00	-0.01
Land	0.19	0.19	0.19	0.19	0.19
Buildings	2.57	2.57	2.57	2.57	2.26
Machinery	1.31	1.31	1.3	1.23	0.42

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 24, 2026

Data Sources Report a data error